---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-045350"
form_type: "8-K"
ticker: "NEO"
cik: "0001077183"
company_name: "NEOGENOMICS INC"
filed_at: "2026-06-25T11:10:14+00:00"
generated_at: "2026-06-25T11:15:21.449366+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# NeoGenomics appoints Carolyn Starrett, former Flatiron Health CEO, to board

## Summary
- Board expanded from 9 to 10 directors; Starrett fills new seat effective June 23, 2026.
- Starrett brings 25+ years experience in data/tech, AI, and cancer care; was CEO of Flatiron Health from 2021-2025.
- She will serve until 2027 annual meeting; compensation per standard director program.
- Chair Lynn Tetrault cites Starrett's expertise in real-world data and analytics for cancer care.

## SEC filing metadata
- accession: 0001628280-26-045350
- form_type: 8-K
- ticker: NEO
- cik: 0001077183
- company_name: NEOGENOMICS INC
- filed_at: 2026-06-25T11:10:14+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1077183/000162828026045350/0001628280-26-045350-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1077183/000162828026045350/neo-20260623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-045350
- JSON: https://secwatch.observer/filing/0001628280-26-045350.json
- Plain text: https://secwatch.observer/filing/0001628280-26-045350.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.